primari
object
random
control
trial
determin
whether
egg
yolk
antibodi
fed
upon
arriv
calf
ranch
would
lower
preval
cryptosporidium
parvum
shed
natur
challeng
prewean
dairi
calv
secondari
object
includ
measur
effect
antibodi
calf
health
perform
shed
less
common
diarrheal
pathogen
total
calv
enrol
h
age
receiv
daili
dose
g
egg
yolk
powder
antibodi
mab
n
without
antibodi
mep
n
split
feed
first
feed
calf
ranch
daili
health
evalu
complet
arriv
digit
weight
collect
enrol
hipomet
weight
collect
enrol
pack
cell
volum
serum
total
protein
concentr
measur
enrol
fecal
ph
measur
enrol
fecal
pathogen
c
parvum
coronaviru
rotaviru
salmonella
spp
shed
assess
continu
outcom
compar
group
use
student
ttest
wilcoxon
rank
sum
test
fecal
pathogen
shed
respiratori
diseas
antibiot
usag
compar
use
rel
risk
rr
chisquar
test
fecal
ph
median
interquartil
rang
mab
mep
respect
risk
respiratori
diseas
lower
mab
compar
mep
rr
confid
interv
risk
antibiot
treatment
lower
mabcompar
meptreat
calv
rr
confid
interv
risk
shed
rotaviru
higher
mab
rr
confid
interv
calv
multivari
analys
hipomet
weight
least
squar
mean
standard
error
kg
greater
mab
compar
mep
howev
adg
kgd
lower
mab
calv
total
health
score
diarrhea
day
averag
respiratori
score
pack
cell
volum
serum
total
protein
affect
feed
egg
antibodi
summari
feed
antibodi
associ
increas
fecal
ph
reduc
risk
respiratori
diseas
later
prewean
period
decreas
antibiot
usag
despit
higher
rotaviru
infect
find
might
associ
improv
mucos
immun
enhanc
host
defens
reduc
suscept
warrant
investig
neonat
calf
diarrhea
ncd
bovin
respiratori
diseas
brd
common
caus
morbid
mortal
prewean
dairi
calv
windey
et
al
cramer
stanton
although
ncd
brd
may
independ
event
affect
calv
wean
risk
brd
increas
calv
diseas
problem
ncd
first
life
windey
et
al
effect
prevent
detect
treatment
paramount
control
ncd
therefor
brd
develop
farm
protocol
challeng
mix
array
caus
organ
viral
bacteri
parasit
preval
mix
infect
potenti
role
nutrit
cryptosporidium
parvum
rotaviru
coronaviru
salmonella
spp
import
enteropathogen
calv
mcguirk
treatment
challeng
approv
antimicrobi
drug
question
efficaci
smith
antibiot
use
may
increas
emerg
resist
bacteria
berg
et
al
effect
treatment
prevent
option
passiv
transfer
matern
antibodi
remain
mainstay
manag
ncd
howev
recent
studi
provid
evid
effect
egg
yolkderiv
antibodi
protect
diarrhea
yokoyama
et
al
mine
kovacsnolan
vega
et
al
diraviyam
et
al
egg
yolk
antibodi
target
lumin
content
lumin
receptor
specif
pathogen
salmonella
typhimurium
salmonella
dublin
absorb
gut
closur
vega
et
al
protect
calv
diseas
yokoyama
et
al
diraviyam
et
al
pose
food
safeti
concern
cook
trott
immunoglobulin
igi
major
antibodi
egg
yolk
function
similar
mammalian
igg
econom
feasibl
produc
noninvas
manner
lee
et
al
caus
ncd
protozo
infect
due
c
parvum
particularli
challeng
high
preval
organ
environment
persist
public
health
concern
nydam
moham
particular
c
parvum
caus
enterocyt
chang
result
diarrhea
dehydr
abnorm
gut
ferment
larg
bowel
produc
fecal
acid
sato
wyatt
et
al
recoveri
c
parvum
depend
larg
cytotox
activ
involv
helper
respons
weaver
et
al
wyatt
et
al
specif
calv
recov
c
parvum
infect
ifngamma
igg
document
signifi
helper
respons
wyatt
et
al
research
shown
protect
helper
immun
respons
suppress
antiinflammatori
cytokin
produc
intraepitheli
lymphocyt
calv
infect
c
parvum
wyatt
et
al
knockout
mice
resist
c
parvum
infect
campbel
et
al
suggest
induct
may
prolong
c
parvum
infect
slow
recoveri
provis
oral
antibodi
broiler
chicken
infect
coccidian
parasit
eimeria
spp
elimin
growth
depress
sand
et
al
therefor
primari
object
studi
determin
whether
egg
yolk
antibodi
fed
upon
arriv
calf
ranch
would
lower
fecal
shed
c
parvum
prewean
dairi
calv
natur
exposur
secondari
object
includ
measur
effect
antibodi
calf
health
perform
fecal
acid
shed
less
common
diarrheal
pathogen
studi
perform
singl
calfrais
facil
southwest
wisconsin
total
calv
sourc
dairi
enrol
wk
period
juli
august
arriv
calfrais
oper
calv
h
age
day
enrol
administ
colostrum
home
farm
male
femal
holstein
jersey
calv
includ
random
number
gener
use
enrol
day
random
calv
colorcod
group
receiv
daili
dose
g
egg
yolk
powder
antibodi
mab
green
purpl
without
antibodi
mep
orang
colorcod
zip
tie
attach
outdoor
hutch
ensur
calv
receiv
correct
dose
calf
feeder
health
screener
farm
personnel
blind
color
code
studi
approv
research
anim
resourc
center
anim
care
use
committe
school
veterinari
medicin
univers
wisconsinmadison
protocol
upon
arriv
calv
hous
indoor
individu
pen
straw
bed
natur
ventil
barn
calv
nurs
well
bottl
calv
move
individu
outdoor
hutch
remain
durat
studi
calv
fed
pasteur
wast
milk
nippl
bottl
calv
fed
l
twice
per
day
interv
indoor
hous
outdoor
hutch
calv
fed
l
time
day
fed
l
twice
daili
calv
fed
l
daili
wean
water
calf
starter
textur
feed
offer
upon
arriv
outdoor
calf
hutch
singl
comb
white
leghorn
lay
hen
rais
life
cage
rais
wire
inject
conjug
per
chicken
bovin
gamma
globulinvmpqaenh
conjug
emulsifi
freund
complet
adjuv
volvol
thermo
fisher
scientif
inc
waltham
total
volum
ml
per
chicken
protein
sequenc
vmpqaenh
use
conjug
carrier
protein
bovin
gamma
globulin
sequenc
vmpqaenh
portion
sequenc
use
make
antibodi
use
dairi
calv
protein
sequenc
made
genscript
piscataway
nj
hen
inject
adjuv
bovin
gamma
globulin
peptid
conjug
use
make
control
antibodi
chicken
inject
wk
later
use
antigen
describ
egg
collect
begin
wk
initi
inject
period
wk
egg
yolk
separ
albumen
lyophil
store
room
temperatur
need
enzymelink
immunosorb
assay
use
determin
titer
antibodi
calv
experiment
group
administ
g
egg
yolk
powder
per
day
divid
daili
milk
feed
total
dose
gkg
dm
first
feed
consid
major
challeng
period
pathogen
associ
ncd
dri
egg
powder
mix
water
make
individu
calf
aliquot
ml
egg
yolk
solut
ad
bottl
pasteur
whole
milk
twice
daili
day
enrol
total
dose
use
translat
dose
previous
effect
poultri
small
trial
postwean
steer
e
cook
j
sand
unpublish
data
daili
health
screen
perform
wean
attitud
appetit
rectal
temperatur
ear
posit
ocular
discharg
nasal
discharg
presenc
spontan
induc
cough
umbilicu
joint
fecal
consist
grade
use
normal
sever
abnorm
system
mcguirk
peek
base
result
exam
total
health
score
calcul
calf
calv
respiratori
score
higher
consid
posit
respiratori
diseas
provid
least
clinic
sign
respiratori
diseas
temperatur
ear
posit
ocular
discharg
nasal
discharg
cough
score
mcguirk
peek
cumul
health
score
treatment
group
calcul
sum
total
health
score
day
calv
within
treatment
group
calv
fecal
score
consid
posit
diarrhea
purpos
analysi
navel
infect
defin
navel
score
farm
staff
provid
result
daili
health
screen
jugular
blood
collect
use
vacutain
needl
monoject
sherwood
medic
compani
st
loui
mo
bd
vacutain
edta
tube
becton
dickinson
compani
franklin
lake
nj
monitor
pack
cell
volum
pcv
enrol
day
blood
collect
bd
vacutain
tube
without
addit
becton
dickinson
compani
measur
serum
total
protein
stp
proxi
passiv
transfer
matern
antibodi
microhematocrit
tube
thermo
fisher
scientif
inc
serum
collect
centrifug
g
min
iec
mb
centrifug
intern
equip
compani
nashvil
tn
stp
determin
use
palm
abb
digit
handheld
refractomet
misco
minneapoli
mn
microhematocrit
tube
thermo
fisher
scientif
inc
use
centrifug
whole
blood
g
min
pcv
measur
use
microhematocrit
reader
chart
vin
davi
ca
plasma
protein
determin
use
palm
abb
digit
handheld
refractomet
failur
passiv
transfer
defin
stp
gdl
digit
weight
kg
optima
calf
scale
op
rancho
cucamonga
ca
record
use
calcul
adg
hipometerestim
weight
record
hipomet
weight
base
width
greater
trochant
left
right
femur
previous
describ
dingwel
et
al
antibiot
usag
farm
personnel
retriev
farm
computer
record
end
trial
cost
per
calf
calcul
divid
total
cost
antibiot
use
within
group
total
number
calv
treatment
group
antibiot
cost
base
wholesal
price
current
time
studi
fecal
sampl
collect
calf
held
room
temperatur
transport
test
fecal
ph
submit
salmonella
spp
cultur
multiplex
reversetranscriptas
pcr
test
proxi
proper
intestin
colon
function
sato
fecal
ph
measur
mix
ml
fece
ml
deioniz
water
directli
place
fecal
solut
sensor
calibr
ph
meter
laqua
twin
ph
meter
horiba
intern
corpor
kyoto
japan
cultur
salmonella
spp
perform
asept
ad
g
fece
ml
rappaport
vassiliadi
broth
remel
lenexa
ks
ml
selenit
broth
remel
enrich
broth
incub
overnight
streak
onto
agar
remel
reincub
h
presumpt
black
coloni
salmonella
spp
isol
identifi
biochem
use
semiautom
system
accord
manufactur
instruct
vitek
compact
system
inc
hazelwood
mo
serotyp
isol
identifi
salmonella
spp
determin
wisconsin
veterinari
diagnost
laboratori
madison
wi
accord
kauffmannwhit
scheme
use
commerci
avail
type
sera
c
parvum
rotaviru
coronaviru
multiplex
reversetranscriptas
pcr
test
cho
et
al
also
complet
wisconsin
veterinari
diagnost
laboratori
calv
consid
posit
shed
c
parvum
rotaviru
coronaviru
cyclethreshold
valu
pathogen
less
cutoff
determin
wisconsin
veterinari
diagnost
laboratori
cyclethreshold
valu
indic
low
amount
target
nucleic
acid
may
repres
earli
infect
environment
contamin
sampl
size
driven
expect
reduct
preval
c
parvum
shed
proport
test
posit
natur
occur
exposur
histor
approxim
calv
test
posit
fecal
shed
calf
ranch
sampl
size
approxim
calv
per
group
select
base
clinic
experi
investig
mcguirk
cook
j
sand
base
sampl
size
would
need
see
differ
reach
power
power
procedur
sa
sa
institut
inc
cari
nc
author
felt
reason
achiev
reduc
preval
shed
base
previou
experi
use
antibodi
speci
continu
variabl
outcom
visual
assess
normal
use
histogram
variabl
follow
normal
distribut
compar
use
student
ttest
includ
pcv
stp
adg
comparison
treatment
group
continu
variabl
follow
normal
distribut
fecal
ph
chang
fecal
ph
fecal
pathogen
shed
hipomet
estim
weight
antibiot
cost
cumul
health
score
compar
use
wilcoxon
rank
sum
test
r
studio
softwar
version
rstudio
inc
boston
http
www
rstudio
com
wilcoxon
rank
sum
test
test
null
hypothesi
outcom
distribut
differ
group
dickinson
gibbon
chakraborti
distribut
wilcoxon
rank
sum
test
act
test
median
simpl
conting
tabl
creat
rel
risk
calcul
fecal
pathogen
shed
respiratori
diseas
antibiot
usag
medcalcorg
comparison
group
proport
calv
test
posit
diarrhea
clinic
respiratori
diseas
throughout
studi
period
assess
use
chisquar
test
multivari
linear
regress
model
mix
procedur
sa
fit
determin
effect
treatment
calf
growth
data
hipomet
weight
arriv
hipomet
weight
chang
hipomet
weight
arriv
adg
univari
analysi
explanatori
variabl
result
p
includ
fix
effect
multivari
model
explanatori
variabl
check
univari
analysi
includ
calf
sex
male
femal
arriv
weight
low
hipomet
weight
median
arriv
weight
high
hipomet
weight
median
arriv
weight
navel
infect
ye
biolog
plausibl
interact
test
signific
manual
backward
stepwis
elimin
use
reduc
model
remain
variabl
signific
level
final
model
assess
graphic
outlier
influenti
observ
normal
use
plot
fit
valu
versu
student
residu
cook
distanc
leverag
multivari
logist
regress
model
glimmix
procedur
sa
fit
determin
effect
treatment
probabl
respiratori
diseas
antibiot
treatment
univari
analysi
explanatori
variabl
result
p
includ
fix
effect
multivari
model
explanatori
variabl
check
univari
analysi
includ
calf
sex
male
femal
arriv
weight
low
hipomet
weight
median
arriv
weight
high
hipomet
weight
median
arriv
weight
navel
ye
biolog
plausibl
interact
test
signific
manual
backward
stepwis
elimin
use
reduc
model
remain
variabl
signific
level
treatment
group
variabl
retain
final
model
total
calv
enrol
studi
mab
n
mep
n
one
jersey
calf
enrol
subsequ
remov
analysi
therefor
final
studi
popul
consist
holstein
calv
bull
calv
made
treatment
control
group
respect
fourteen
mab
mep
calv
fail
produc
adequ
fecal
specimen
therefor
exclud
analys
health
score
miss
singl
day
calv
one
mab
one
mep
total
health
score
omit
analysi
calv
equival
pcv
stp
concentr
sampl
tabl
calv
die
followup
period
median
fecal
ph
mab
calv
lower
compar
mep
calv
p
figur
higher
mep
calv
p
figur
upon
arriv
raw
hipometerderiv
weight
median
iqr
kg
kg
mab
mep
calv
respect
p
hipomet
weight
median
iqr
kg
kg
mab
mep
calv
respect
p
differ
hipomet
estim
weight
enrol
higher
mab
group
median
kg
iqr
compar
mep
group
median
kg
iqr
p
raw
adg
mab
calv
kgd
adg
mep
calv
kgd
p
multivari
linear
regress
model
also
fit
calf
growth
data
control
navel
tabl
pack
cell
volum
serum
total
protein
concentr
mean
sd
arriv
calf
ranch
prewean
dairi
calv
receiv
daili
dose
g
egg
yolk
powder
antibodi
mab
n
without
antibodi
mep
n
pack
cell
volum
serum
total
protein
mgdl
n
lower
mep
group
iqr
n
b
median
fecal
ph
higher
mab
group
iqr
n
compar
mep
group
iqr
n
note
differ
yaxi
scale
group
median
differ
letter
b
significantli
differ
p
whisker
indic
lowest
highest
observ
infect
hipomet
weight
lsm
se
upon
arriv
kg
mab
mep
calv
p
hipomet
weight
kg
kg
mab
mep
calv
respect
p
control
arriv
weight
similarli
control
arriv
weight
differ
hipomet
weight
arriv
kg
kg
mab
mep
calv
respect
p
last
adg
kgd
kgd
mab
mep
calv
respect
p
control
calf
sex
arriv
weight
navel
infect
interact
arriv
weight
navel
infect
rotaviru
predomin
fecal
pathogen
detect
wherea
c
parvum
predomin
pathogen
tabl
salmonella
montevideo
n
salmonella
newport
n
cultur
total
calv
fecal
coronaviru
detect
calv
low
preval
salmonella
spp
coronaviru
shed
analyz
cyclethreshold
valu
median
iqr
c
parvum
rotaviru
describ
tabl
overal
risk
shed
rotaviru
greater
mab
calv
compar
mep
calv
rr
ci
p
overal
risk
shed
c
parvum
differ
group
rr
ci
p
author
knowledg
first
random
clinic
trial
show
feed
egg
yolk
antibodi
pasteur
wast
milk
dairi
calv
safe
feasibl
treat
calv
fecal
ph
calv
studi
fell
expect
rang
enrol
acidifi
age
previous
describ
shimomura
sato
mab
group
show
less
fecal
acidif
time
mep
calv
suggest
immatur
microflora
colon
treat
calv
might
produc
less
lactat
vfa
shimomura
sato
sato
lower
colon
ph
associ
colon
epitheli
damag
well
osmot
diarrhea
shimomura
sato
sato
regard
young
dairi
calv
c
parvum
infect
associ
malabsorpt
carbohydr
may
respons
increas
lactat
ferment
fecal
acidif
higher
fecal
ph
mab
group
follow
enrol
may
provid
evid
improv
small
intestin
absorpt
carbohydr
group
reduc
risk
respiratori
diseas
well
antibiot
treatment
mab
group
unexpect
although
possibl
find
spuriou
other
shown
increas
risk
brd
later
prewean
period
calv
earlier
diseas
problem
ncd
first
wk
life
windey
et
al
possibl
stabil
fecal
ph
young
calv
demonstr
current
studi
unmeasur
chang
gastrointestin
function
effect
develop
clinic
respiratori
diseas
later
prewean
period
mechan
improv
respiratori
health
seen
improv
gastrointestin
health
unknown
howev
literatur
suggest
pulmonaryintestin
crosstalk
given
similar
epitheli
surfac
mucosaassoci
lymphoid
tissu
keeli
et
al
similar
share
immun
compon
overlap
patholog
chang
inflamm
note
human
respiratori
intestin
mucos
diseas
keeli
et
al
mcghee
fujihashi
although
antibiot
administr
primarili
treatment
respiratori
diseas
farm
personnel
respons
treatment
decis
blind
treatment
group
made
awar
daili
health
score
therefor
bia
level
farm
personnel
drive
observ
differ
detect
signific
differ
level
c
parvum
shed
risk
shed
studi
previou
research
shown
elimin
c
parvum
infect
knockout
mice
reduc
oocyst
shed
eimeriainfect
chicken
campbel
et
al
sand
et
al
addit
research
warrant
complet
rule
antibodi
potenti
prevent
c
parvum
also
detect
signific
differ
median
level
rotaviru
shed
group
base
cyclethreshold
valu
howev
risk
rotaviru
shed
mab
group
increas
might
suggest
bind
may
neg
affect
immun
respons
specif
rotaviru
reduc
infect
increas
passag
viru
hipomet
estim
weight
benefit
seen
differ
measur
taken
enrol
mab
calv
may
indic
improv
statur
frame
size
rather
weight
improv
statur
wean
import
futur
perform
dairi
calv
howev
find
interpret
caution
agreement
hipometerestim
digit
weight
question
calv
less
mo
age
dingwel
et
al
studi
limit
sampl
size
calf
number
depend
calfrais
manag
practic
includ
daili
variat
number
age
breed
sex
calv
deliv
sourc
farm
limit
durat
calf
enrol
period
research
use
result
studi
determin
sampl
size
futur
studi
studi
need
elucid
mechan
improv
fecal
ph
reduc
respiratori
diseas
increas
hipomet
measur
longterm
implic
chang
reduc
antibiot
use
prewean
calv
suggest
studi
substant
econom
welfar
potenti
consum
benefit
treatment
dose
durat
explor
valid
effect
antibodi
respiratori
health
calf
growth
fecal
pathogen
shed
feed
egg
yolk
antibodi
pasteur
milk
upon
arriv
calf
ranch
chang
proport
calv
test
posit
c
parvum
despit
find
treat
calv
maintain
fecal
ph
develop
larger
frame
less
like
receiv
antibiot
diagnos
respiratori
diseas
wean
suggest
benefit
feed
antibodi
futur
research
need
confirm
benefici
differ
repeat
result
feed
addit
studi
also
investig
differ
dose
strategi
look
closer
effect
egg
yolk
antibodi
respiratori
health
